Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccines against gut pathogens.

× No keyword cloud information.

28 in total

1. Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.

Authors: D N Taylor; J L Sanchez; J M Castro; C Lebron; C M Parrado; D E Johnson; C O Tacket; G A Losonsky; S S Wasserman; M M Levine; S J Cryz
Journal: Infect Immun Date: 1999-04 Impact factor: 3.441

2. Optimism over vaccines administered via mucosal surfaces.

Authors: M M Levine; G Dougan
Journal: Lancet Date: 1998-05-09 Impact factor: 79.321

Review 3. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors: M M Levine; J B Kaper; R E Black; M L Clements
Journal: Microbiol Rev Date: 1983-12

4. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors: S K Hoiseth; B A Stocker
Journal: Nature Date: 1981-05-21 Impact factor: 49.962

5. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors: N Lycke; J Holmgren
Journal: Immunology Date: 1986-10 Impact factor: 7.397

Review 6. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases.

Authors: O G Gómez-Duarte; D Bumann; T F Meyer
Journal: Vaccine Date: 1999-03-26 Impact factor: 3.641

Review 7. Progress in vaccines against typhoid fever.

Authors: M M Levine; C Ferreccio; R E Black; C O Tacket; R Germanier
Journal: Rev Infect Dis Date: 1989 May-Jun

8. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.

Authors: C O Tacket; D M Hone; R Curtiss; S M Kelly; G Losonsky; L Guers; A M Harris; R Edelman; M M Levine
Journal: Infect Immun Date: 1992-02 Impact factor: 3.441

9. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.

Authors: P Michetti; C Kreiss; K L Kotloff; N Porta; J L Blanco; D Bachmann; M Herranz; P F Saldinger; I Corthésy-Theulaz; G Losonsky; R Nichols; J Simon; M Stolte; S Ackerman; T P Monath; A L Blum
Journal: Gastroenterology Date: 1999-04 Impact factor: 22.682

10. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Authors: M Marchetti; M Rossi; V Giannelli; M M Giuliani; M Pizza; S Censini; A Covacci; P Massari; C Pagliaccia; R Manetti; J L Telford; G Douce; G Dougan; R Rappuoli; P Ghiara
Journal: Vaccine Date: 1998-01 Impact factor: 3.641

3 in total

1. Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.

Authors: Xiao-Feng Liu; Jia-Lu Hu; Qi-Zheng Quan; Zi-Qin Sun; Yao-Jun Wang; Feng Qi
Journal: World J Gastroenterol Date: 2005-04-14 Impact factor: 5.742

Review 2. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors: Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal: Adv Drug Deliv Rev Date: 2012-10-23 Impact factor: 15.470

3. Development of Salmonella Enteritidis vaccine candidate based on streptomycin independent suppressor and metabolic drift rifampicin resistance-attenuating markers.

Authors: Awad A Shehata; Reda Tarabees; Mohamed Elsayed; Gamal Wareth; Shereen Basiouni
Journal: Heliyon Date: 2020-08-28

3 in total